Bisphosphonates are a class of drugs that drug companies claim promote bone regeneration. Bisphosphonates are commonly sold under various brand names including Fosamax®, Actonel®, Aredia® and Zometa®.

These drugs are manufactured by pharmaceutical companies such as Merck, Novartis, Proctor & Gamble and Sanofi-Aventis. Bisphosphonates are used to treat, among other things, osteoporosis, bone metastasis during cancer treatment, osteoarthritis and other conditions that feature bone fragility. Studies show that bisphosphonate treatment can cause severe side-effects including Osteonecrosis of the Jaw and low-trauma bone fractures.

Recently, Fosamax, the popular drug used to treat osteoporosis, has been linked to severe injuries including Osteonecrosis of the Jaw (also known as Fossy Jaw, Dead Jaw and Phossy Jaw), low-energy femur fractures and severe and painful injuries affecting bones, joints and muscles. Last year the Food and Drug Administration (FDA) warned that Fosamax, and other bisphosphonates including Actonel, Aredia and Zometa, had been linked to these severe side effects and urged the public to discontinue use of the drug if they have experienced any of these injuries.

Stark & Stark’s Mass Tort attorneys protect the rights of those injured and strive to obtain the maximum compensation possible for those injured and their families. Our attorneys are committed to assisting clients injured through the negligent and sometimes intentional acts of producing, marketing and distributing defective pharmaceutical drugs.

The Mass Tort Team of Stark & Stark is now reviewing potential claims for individuals who have suffered a serious injury from Fosamax. If you or a loved one have suffered a serious injury due to Fosamax, please contact an experienced injury attorney in order to have your claim reviewed.